Status:
UNKNOWN
Cardiorespiratory Performance and Pulmonary Microbiome in Patients After Repair of Esophageal Atresia
Lead Sponsor:
Medical University of Graz
Conditions:
Esophageal Atresia
Eligibility:
All Genders
12+ years
Phase:
NA
Brief Summary
The majority of the clinical research on esophageal atresia focuses on the upper gastrointestinal tract. However, the trachea and the lung are also affected in many of these children, so that a lifelo...
Eligibility Criteria
Inclusion
- Age from 12 years
- Status post surgical correction of esophageal atresia with and without fistula
- Granted consent
Exclusion
- Acute infections within the last 14 days
- Other associated serious malformations
- Acute, temporary respiratory complaints (cough, allergies etc.)
- Physical and mental illnesses or disabilities that do not allow the examination to be carried out
- non-granted consent
Key Trial Info
Start Date :
August 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 2 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03767673
Start Date
August 10 2017
End Date
September 2 2019
Last Update
December 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Graz
Graz, Austria, 8010